Search Results

Your search for Alexander B. Pine, MD, PhD, and Alfred I. Lee, MD matches 2 pages

Showing 1 - 2

By Alexander B. Pine, MD, PhD, and Alfred I. Lee, MD / Wednesday, February 6, 2019 6:07 PM

Letter to the Editor: Survey on DOACs in Cancer-Related Venous Thromboembolism

This letter is a follow-up to a report published previously in The ASCO Post. Recent trials report comparable or improved efficacy of direct-acting oral coagulants (DOACs) over low–molecular-weight heparins (LMWH) in the treatment of cancer-related VTE (cVTE) at the expense of increased...

symptom management

By Alexander B. Pine, MD, PhD, and Alfred I. Lee, MD, PhD / December 25, 2018

Clinician Survey to Explore Direct-Acting Oral Anticoagulants vs Low–Molecular-Weight Heparin in Cancer-Related VTE

Injectable low–molecular-weight heparin has long been considered the standard of care for treatment of venous thromboembolism (VTE) in patients with cancer. However, low–molecular-weight heparin is costly and often disliked by patients due to injection-related discomfort and bruising....

Nov

Today In Oncology

Search Results

Your search for Alexander B. Pine, MD, PhD, and Alfred I. Lee, MD matches 2 pages

Letter to the Editor: Survey on DOACs in Cancer-Related Venous Thromboembolism

Clinician Survey to Explore Direct-Acting Oral Anticoagulants vs Low–Molecular-Weight Heparin in Cancer-Related VTE

Addition of Hyperthermic Intraperitoneal Chemotherapy to Surgery for Recurrent Ovarian Cancer

Penpulimab Combination Therapy for First-Line Treatment of Hepatocellular Carcinoma

Global Adaptive Platform Trial for Glioblastoma to Evaluate Novel ATM Kinase Inhibitor

Healthy Women May Have Aneuploid Epithelial Cells Resembling Breast Cancer

Perioperative Toripalimab in Locoregionally Advanced Nasopharyngeal Carcinoma